This inventor holds 1 USPTO granted patent. Top assignee: Regents of the University of Minnesota. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tej Poudel: Innovator in Antiviral Research
Introduction
Tej Poudel is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of antiviral research, particularly in the development of next-generation remdesivir antivirals. His work focuses on innovative compounds that aim to treat pulmonary infections caused by various coronaviruses.
Latest Patents
Tej Poudel holds 1 patent for his groundbreaking work. His patent, titled "Next generation remdesivir antivirals," relates to compounds of specific formulas and pharmaceutical compositions. These compounds are designed to treat pulmonary infections, including those caused by SARS-COV, MERS-COV, and SARS-COV-2.
Career Highlights
Tej Poudel is affiliated with the Regents of the University of Minnesota, where he conducts his research. His dedication to advancing antiviral therapies has positioned him as a key figure in the scientific community. His innovative approach to drug development is paving the way for more effective treatments.
Collaborations
Tej collaborates with Subhankar Panda, a fellow researcher, to enhance the scope and impact of their work. Their partnership exemplifies the importance of teamwork in scientific research.
Conclusion
Tej Poudel's contributions to antiviral research are noteworthy, and his patent on next-generation remdesivir antivirals showcases his innovative spirit. His work continues to inspire advancements in the treatment of pulmonary infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile